This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 3 months, 3 weeks ago.

  • Author
    Posts
  • #20135

    Our latest flash briefing discusses a trials’ data that shows how Ofev benefits IPF patients irrespective of initial prognosis.

    What are your thoughts about this trial and its findings?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account